Psychiatry & Mental Health Clinical Trials

Statistical methods in psychiatry & mental health trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All psychiatry & mental health trials

833 results

• Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 734NCT01085812
• REST-ITIndependent statistical analysis of Reducing Suicidal Ideation Through Insomnia Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01689909).Phase 4Results postedn = 103NCT01689909
• RLS-PractiseIndependent statistical analysis of Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 687NCT01113710
• RPCWIndependent statistical analysis of Prevention of Alcohol-related Sexual Revictimization in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257603).Phase NAResults postedn = 72NCT05257603
• SADHART-CHFIndependent statistical analysis of Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2/3Results postedn = 469NCT00078286
• SAFERIndependent statistical analysis of Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 400NCT01351389
• SayWhenIndependent statistical analysis of Better Than Study: Targeting Heavy Alcohol Use With Naltrexone Among Men Who Have Sex With Men (MSM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 120NCT02330419
• SBIRT-PTSDIndependent statistical analysis of Evaluation and Treatment of Substance Abuse in Veterans With PTSD Disability Claims: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 346NCT01597856
• SDFCIndependent statistical analysis of Olfactory Contributions to Sleep-dependent Food Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04179838).Phase NAResults postedn = 29NCT04179838
• SERENITY IIIndependent statistical analysis of Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04276883).Phase 3Results postedn = 380NCT04276883
• Sert2Independent statistical analysis of A Trial of Sertraline in Young Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 58NCT02385799
• SHINEIndependent statistical analysis of A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 336NCT03893825
• SiyakhanaIndependent statistical analysis of Community Health Worker Training to Reduce Depression and Substance Use Stigma in TB/HIV Care in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 82NCT05282173
• SLD3Independent statistical analysis of Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 81NCT02736695
• SLUMBERIndependent statistical analysis of Improving Sleep Using Mentored Behavioral and Environmental Restructuring: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03327324).Phase NAResults postedn = 110NCT03327324
• SOLEOIndependent statistical analysis of A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 99NCT06340958
• SPIN-CHATIndependent statistical analysis of Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 172NCT04335279
• STAR*DA detailed statistical analysis and educational interpretation of STAR*D, a phase 4 clinical study evaluating the relationship between depression symptoms and brain physiologic measures during antidepressant treatment.Phase 4n = 118NCT00375843
• STEP 210Independent statistical analysis of Multicenter, Open-label, Safety and Tolerability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01649557).Phase 2Results postedn = 244NCT01649557
• STEP-BDAn independent statistical analysis and educational interpretation of STEP-BD, a randomized, double-blind treatment study in bipolar disorder with an enrollment of 5,000 participants.Phase NAn = 5,000NCT00012558
• STEP-HomeIndependent statistical analysis of Multisite RCT of STEP-Home: A Transdiagnostic Skill-based Community Reintegration Workshop: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03868930).Phase NAResults postedn = 221NCT03868930
• STOP-TICIndependent statistical analysis of Combined CBIT and rTMS to Improve Tourette's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04795908).Phase NAResults postedn = 3NCT04795908
• TAP-PIndependent statistical analysis of Can a Novel Telemedicine Tool Reduce Disparities Related to the Identification of Preschool Children With Autism?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 148NCT05373173
• TECH-EIndependent statistical analysis of Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 73NCT05376358
• TIPIndependent statistical analysis of Development and Evaluation of a Tonic Immobility Focused Psychoeducational Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05113277).Phase NAResults postedn = 51NCT05113277
• TPMIIndependent statistical analysis of Improving Prospective Memory Via Telehealth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05129293).Phase NAResults postedn = 35NCT05129293
• urochesterIndependent statistical analysis of Feasibility of the Memory and Attention Adaptation-Training Geriatrics Intervention in Older Cancer Survivors With Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 12NCT05258058
• VAST-DComplete statistical analysis of VAST-D, the phase 3 randomized trial of switching to bupropion-SR versus augmentation with bupropion-SR or aripiprazole for major depressive disorder, including remission, response, relapse, statistical methodology, safety, and…Phase 3Results postedn = 1,522NCT01421342
• VITALIndependent statistical analysis of A Study of Dog Adoption in Veterans With Posttraumatic Stress Disorder (PTSD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase EARLY_1Results postedn = 19NCT01729026
• VOR-IISRIndependent statistical analysis of Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02969876).Phase 4Results postedn = 2NCT02969876
• VR-THEIAIndependent statistical analysis of Impact of Virtual Reality on Pre-procedural anxieTy Prior to Heart cathEterIzAtion - VR-THEIA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 180NCT03662607
• VRPE ExtensionIndependent statistical analysis of Comparing Virtual Reality Exposure Therapy to Prolonged Exposure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01459705).Phase NAResults postedn = 162NCT01459705
• WRAPIndependent statistical analysis of Neurocognitive Factors in Substance Use Treatment Response: The Ways of Rewarding Abstinence Project: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 63NCT03799341

← All therapeutic areas